Myelin-H

Digitize healthcare: We help doctors monitor, and treat neurological diseases remotely. The right treatement fot the right patient at the right time.

Key achievements:
Customers: 3 Hospitals in Europe
3 letters of interest from customers in the US
Funded by the Ministry of the economy in Luxembourg through the fit4start program and private Equity

There is no available solution to help doctors remotely and quickly monitor disease progression, assess treatment effectiveness, or even perform a customized therapeutic brain stimulation at home to help similar patients.The existing solutions require doctors have to manually inspect collected signals en route to identifying potential biomarkers.
In parallel, clinical trials for new treatments and research in brain diseases is costly and inefficient due to the lack of new technology to accelerate such research.

Myelin-H is a neurotechnology company developing and licensing biologically inspired software technology to help hospitals, doctors, and biopharma companies perform remote monitoring and treatment of neurological diseases remotely.
Using the same technology, we have developed 3 products:
1. For research to help hospitals and biopharma companies with clinical trials and to accelerate drug development.
2. A software device technology for remote monitoring of patients suffering from multiple sclerosis.
3. For space medicine to help astronauts improve their cognitive performances in orbit.

Myelin-H is a software a Service (SasS) company.
Our model is a yearly subscription to our software with a one time cost for the hardware. We license our software technology to hospitals and biopharma companies (per license per patient per year)

Fit4Start program